Chemistry Ventures, the VC firm launched by Bessemer, Index Ventures, and Andreessen Horowitz alums, is raising $500M for its second fund.
The venture capital market continues to see active fundraising by emerging firms, reflecting ongoing investor appetite for new opportunities and established founders' ability to leverage their networks.
This indicates sustained activity in the venture capital landscape, suggesting continued funding availability for technology startups and the emergence of new, well-connected investment vehicles.
The entry of firms like Chemistry Ventures, backed by established VC alums, adds more competition and potentially new investment theses to the venture capital ecosystem, influencing startup funding dynamics.
- · Chemistry Ventures
- · Early-stage startups
- · Limited partners (LPs) seeking diversification
- · VC firms with less experienced teams
- · Startups in overly competitive sectors without clear differentiation
Chemistry Ventures will have significantly more capital to deploy into emerging technology companies.
Increased competition among VC firms could drive up valuations for promising startups or lead to more specialized investment strategies.
The success of these second funds often encourages more spin-out firms from established VCs, further decentralizing the venture funding landscape.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at TechCrunch — Venture